TradingAgents AISign inGet started
All stock profiles
IBIONASDAQHealthcare

IBIO INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$0.77

-5.52%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze IBIO free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-30.7%

3 months

-45.9%

6 months

-51.6%

1 year

-50.4%

Year to date

-60.2%

52-week range

$0.71 – $3.07

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$49.5M

P/E

-1.5

P/B

0.6

P/S

495

Revenue

$100K

Net income

-$33.04M

Diluted EPS

-0.32

Gross margin

100.00%

Net margin

-33044.00%

Return on equity

-47.90%

Total debt

$2.2M

Cash

$56.62M

Free cash flow

-$23.8M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$10.6M——-$6.25M
Mar 31, 2026$0-$7.73M——-$6.1M
Dec 31, 2025$0-$8.99M——-$5.76M
Sep 30, 2025$100K-$5.72M100.00%-5720.00%-$5.7M
Sep 30, 2025$100K-$5.72M100.00%-5720.00%-$5.7M
Jun 30, 2025$200K-$5.16M100.00%-2581.50%-$4.62M
Mar 31, 2025$0-$4.86M——-$3.12M
Dec 31, 2024$200K-$4.36M100.00%-2182.00%-$3.87M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent IBIO news

All market news

No ticker-linked stories are in the current archive.